UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The Pathophysiologic Role of Monocytes and Macrophages in Systemic Lupus Erythematosus: A Reappraisal

Seminars in arthritis and rheumatism, 2010-06, Vol.39 (6), p.491-503

2010

Volltextzugriff (PDF)

New onset of lupus nephritis in two patients with SLE shortly after initiation of treatment with belimumab

Seminars in arthritis and rheumatism, 2017-06, Vol.46 (6), p.788-790

2017

Volltextzugriff (PDF)

Treatment modalities and drug survival in a systemic sclerosis real-life patient cohort

Arthritis research & therapy, 2020-03, Vol.22 (1), p.56-8, Article 56

2020

Volltextzugriff (PDF)

Treatment of Systemic Sclerosis-Associated Calcinosis: A Case Report of Rituximab-Induced Regression of CREST-Related Calcinosis and Review of the Literature

Seminars in arthritis and rheumatism, 2012-06, Vol.41 (6), p.822-829

2012

Volltextzugriff (PDF)

Immune Checkpoint Inhibitor-Associated Scleroderma-Like Syndrome: A Report of a Pembrolizumab-Induced “Eosinophilic Fasciitis-Like” Case and a Review of the Literature

Rheumatology and therapy., 2020-12, Vol.7 (4), p.1045-1052

2020

Volltextzugriff (PDF)

The future of the IL-1 receptor antagonist anakinra: from rheumatoid arthritis to adult-onset Still's disease and systemic-onset juvenile idiopathic arthritis

Expert opinion on investigational drugs, 2008-03, Vol.17 (3), p.349-359

2008

Volltextzugriff (PDF)

Molecular abnormalities of the B cell in systemic lupus erythematosus are candidates for functional inhibition treatments

Expert opinion on pharmacotherapy, 2014-04, Vol.15 (6), p.833-840

2014

Volltextzugriff (PDF)

Experience with rituximab in scleroderma: results from a 1-year, proof-of-principle study

Rheumatology (Oxford, England), 2010-02, Vol.49 (2), p.271-280

2010

Volltextzugriff (PDF)

Wnt Pathway and IL-17: Novel Regulators of Joint Remodeling in Rheumatic Diseases. Looking Beyond the RANK-RANKL-OPG Axis

Seminars in arthritis and rheumatism, 2010-04, Vol.39 (5), p.369-383

2010

Volltextzugriff (PDF)

Pathogenesis of human systemic lupus erythematosus: recent advances

Trends in molecular medicine, 2010-02, Vol.16 (2), p.47-57

2010

Volltextzugriff (PDF)

Anakinra treatment in patients with adult-onset Still’s disease is fast, effective, safe and steroid sparing: experience from an uncontrolled trial

Annals of the rheumatic diseases, 2007-06, Vol.66 (6), p.842-843

2007

Volltextzugriff (PDF)

The Role of B Cells in Scleroderma Lung Disease Pathogenesis

Frontiers in medicine, 2022-07, Vol.9, p.936182-936182

2022

Volltextzugriff (PDF)

Acute posterior multifocal placoid pigment epitheliopathy in a patient with familial Mediterranean fever

Clinical and experimental optometry, 2016-07, Vol.99 (4), p.385-387

2016

Volltextzugriff (PDF)

B Cell-Based Treatments in SLE: Past Experience and Current Directions

Current rheumatology reports, 2017-11, Vol.19 (12), p.78-78, Article 78

2017

Volltextzugriff (PDF)

Is There a Role for B-cell Depletion as Therapy for Scleroderma? A Case Report and Review of the Literature

Seminars in arthritis and rheumatism, 2010-10, Vol.40 (2), p.127-136

2010

Volltextzugriff (PDF)

B cells tell scleroderma fibroblasts to produce collagen

Arthritis research & therapy, 2013-01, Vol.15 (6), p.125-125, Article 125

2013

Volltextzugriff (PDF)

Treating Autoimmune-Related Interstitial Lung Disease With B Cell Depletion

Frontiers in medicine, 2022-06, Vol.9, p.937561-937561

2022

Volltextzugriff (PDF)

B-cell depletion therapy in patients with diffuse systemic sclerosis associates with a significant decrease in PDGFR expression and activation in spindle-like cells in the skin

Arthritis research & therapy, 2012-06, Vol.14 (3), p.R145-R145, Article R145

2012

Volltextzugriff (PDF)

B cell depletion treatment decreases CD4+IL4+ and CD4+CD40L+ T cells in patients with systemic sclerosis

Rheumatology international, 2019-11, Vol.39 (11), p.1889-1898

2019

Volltextzugriff (PDF)

B-Cell Depletion Therapy in Systemic Sclerosis: Experimental Rationale and Update on Clinical Evidence

International Journal of Rheumatology, 2011-01, Vol.2011 (2011), p.35-41

2011

Volltextzugriff (PDF)

Targeting CD40L: a promising therapeutic approach

Clinical and diagnostic laboratory immunology, 2004-07, Vol.11 (4), p.635-641

2004

Volltextzugriff (PDF)

The Potential Role of Lyn Kinase in Systemic Lupus Erythematosus and Autoimmunity

The Israel Medical Association journal, 2016-09, Vol.18 (9), p.513-515

2016

Volltextzugriff (PDF)

From Basic Immunology to Clinical Practice: Bio-Originators versus Bio-Similars

Mediterranean journal of rheumatology, 2019, Vol.30 (Suppl 1), p.54

2019

Volltextzugriff (PDF)

Man-in-a-barrel syndrome: a rare presentation of giant cell arteritis

Clinical and experimental rheumatology, 2022-05

2022

Volltextzugriff (PDF)

A 40-Year-Old Woman with Asymmetric Arthritis and Skin Lesions

Mediterranean journal of rheumatology, 2019, Vol.30 (3), p.190

2019

Volltextzugriff (PDF)

1 – 25 von 58

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieClinical Immunology

Zeitschrift / SerieClinical Immunology And Immunopathology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(43)
Mit Volltextzugriff
(47)

Publikationsform

Artikel
(57)
Berichte
(1)

Sprache

Englisch
(58)

Erscheinungsjahr

n.n

Thema

Humans
(40)
Science & Technology
(39)
Life Sciences & Biomedicine
(36)
Rheumatology
(22)
Female
(16)
Adult
(15)
Animals
(15)
Lupus Erythematosus, Systemic - Immunology
(15)
Male
(15)
Middle Aged
(13)
Systemic Lupus Erythematosus
(13)
Biological And Medical Sciences
(12)
Medical Sciences
(12)
Aged
(10)
Immunology
(9)
Scleroderma
(8)
Lupus Erythematosus, Systemic - Genetics
(7)
Medicine
(7)
Rituximab
(7)
B Cells
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The Pathophysiologic Role of Monocytes and Macrophages in Systemic Lupus Erythematosus: A Reappraisal

New onset of lupus nephritis in two patients with SLE shortly after initiation of treatment with belimumab

Treatment modalities and drug survival in a systemic sclerosis real-life patient cohort

Treatment of Systemic Sclerosis-Associated Calcinosis: A Case Report of Rituximab-Induced Regression of CREST-Related Calcinosis and Review of the Literature

Immune Checkpoint Inhibitor-Associated Scleroderma-Like Syndrome: A Report of a Pembrolizumab-Induced “Eosinophilic Fasciitis-Like” Case and a Review of the Literature

The future of the IL-1 receptor antagonist anakinra: from rheumatoid arthritis to adult-onset Still's disease and systemic-onset juvenile idiopathic arthritis

Molecular abnormalities of the B cell in systemic lupus erythematosus are candidates for functional inhibition treatments

Experience with rituximab in scleroderma: results from a 1-year, proof-of-principle study

Wnt Pathway and IL-17: Novel Regulators of Joint Remodeling in Rheumatic Diseases. Looking Beyond the RANK-RANKL-OPG Axis

Pathogenesis of human systemic lupus erythematosus: recent advances

Anakinra treatment in patients with adult-onset Still’s disease is fast, effective, safe and steroid sparing: experience from an uncontrolled trial

The Role of B Cells in Scleroderma Lung Disease Pathogenesis

Acute posterior multifocal placoid pigment epitheliopathy in a patient with familial Mediterranean fever

B Cell-Based Treatments in SLE: Past Experience and Current Directions

Is There a Role for B-cell Depletion as Therapy for Scleroderma? A Case Report and Review of the Literature

B cells tell scleroderma fibroblasts to produce collagen

Treating Autoimmune-Related Interstitial Lung Disease With B Cell Depletion

B-cell depletion therapy in patients with diffuse systemic sclerosis associates with a significant decrease in PDGFR expression and activation in spindle-like cells in the skin

B cell depletion treatment decreases CD4+IL4+ and CD4+CD40L+ T cells in patients with systemic sclerosis

B-Cell Depletion Therapy in Systemic Sclerosis: Experimental Rationale and Update on Clinical Evidence

Targeting CD40L: a promising therapeutic approach

The Potential Role of Lyn Kinase in Systemic Lupus Erythematosus and Autoimmunity

From Basic Immunology to Clinical Practice: Bio-Originators versus Bio-Similars

Man-in-a-barrel syndrome: a rare presentation of giant cell arteritis

A 40-Year-Old Woman with Asymmetric Arthritis and Skin Lesions

Aktive Filter

Suchergebnisse filtern